Welcome to the ACTIV-6 Study

Welcome to the ACTIV‑6 study

Working together to help people with COVID-19 feel better faster.

For more information or to report a concern, call 833-385-1880 or complete this form.

Welcome to ACTIV‑6!

Thank you for your interest in ACTIV-6. We are truly grateful to clinical trial participants who help advance science and our understanding of treatments for COVID-19. Learn more from Dr. Susanna Naggie, ACTIV-6 principal investigator, in this video.

Why This Study Is Important

Vaccines are available, but access is limited in some areas and new, more transmissible variants of the virus have emerged in the U.S. People are still getting sick, and many remain at risk for the disease.

Results from ACTIV-6 will help researchers understand how existing medications can improve symptoms and limit hospitalizations for people with mild-to-moderate COVID-19.

Study Eligibility

ACTIV-6 may be for you if:

  • You are 30 years old or older.
  • Tested positive for COVID-19 within the past 10 days.
  • Have at least 2 COVID-19 symptoms for 7 days or less. Symptoms include fatigue, difficulty breathing, fever, cough, nausea, vomiting, diarrhea, body aches, chills, headache, sore throat, nasal symptoms, and/or new loss of sense of taste or smell.

You can participate from anywhere in the United States!

ACTIV-6 is a nationwide double-blind study expected to enroll up to 15,000 participants. People can participate in ACTIV-6 from anywhere in the United States via the ACTIV-6 website or call center, 833-385-1880.

Please note: You may participate from anywhere in the United States, even if there is no site near your location.